-
PROVIDERS
REGISTER NOW
What’s Next in Oncology: Research Breakthroughs from the 2025 ASCO® Annual Meeting
Tuesday, August 12th
11:00am PT, 1:00pm CT, 2:00pm ET -
LIFE SCIENCES
REGISTER NOW
Navigating New Frontiers in Breast Cancer Care Pathway Intelligence: The Role of Providers and AI
Tuesday, July 29
2pm PT, 4pm CT, 5pm ET -
PATIENTS
It's About Time
View the Tempus vision.
- RESOURCES
-
ABOUT US
View Job Postings
We’re looking for people who can change the world.
- INVESTORS
Resources
Webinars
-
07/29/2025Navigating New Frontiers in Breast Cancer Care Gap Closure: The Role of Providers and AI
A Deep Dive into Tempus Next's Impact on Precision MedicineSpeakers:
Watch replay -
07/14/2025Closing Care Gaps with AI: The Next Competitive Edge in Pharma
Expert Perspectives on Advancing Adherence to Precision Medicine GuidelinesSpeakers: Ryan Fukushima,
Watch replay
COO, Tempus
Gary Grad,
MD Senior Medical Oncologist, Medical Science, Tempus
Ahmed ElNawawi,
Head of US Commercial Organization, Menarini Stemline -
05/31/2025Industry Expert Theater Presentation* from the 2025 ASCO® Annual Meeting
Powering Today’s Insights for a Smarter Tomorrow: Intelligent Diagnostics and AI Solutions Across the Cancer ContinuumSpeakers: Ezra Cohen, MD, FASCO
Watch replay
Chief Medical Officer of Oncology, Tempus
Kate Sasser, PhD
Chief Scientific Officer, Tempus
Halla Nimeiri, MD
Chief Development Officer, Tempus
-
06/12/2025AI & ML in action: Demonstrating real-world impact in trial design & patient care
Discover how the Tempus platform leverages AI and ML to inform standard of care practices through health equity guidelines and drive insights that help refine clinical trial design.Speakers: Jonathan Ozeran
Watch replay
VP Generative AI, Tempus
Chris Scotto DiVetta
SVP & General Manager of AI Applications -
03/25/2025The RNA advantage: A multimodal approach to accelerating oncology R&D
Discover how transcriptomic data and multi-omics data integrated with AI is helping revolutionize oncology drug development and patient care and fueling precision medicine 2.0. Learn about RNA sequencing’s role in companion diagnostics and Tempus Loop’s capabilities to support target identification and validation.Speakers: Internal:
Watch replay
Justin Guinney, PhD
SVP of Cancer Genomics, Tempus
External:
Rafael Rosengarten, PhD
CEO & Co-founder, Genialis
Sadnip Patel, MD
Professor of Medical Oncology, UC San Diego
-
04/22/2025Alterations Drive Decisions: Advancing Personalized Care with Comprehensive Genomic Profiling
Part 2 of "Are you getting the full picture? A series on the power of comprehensive intelligent diagnostics."Speakers: Internal
Watch replay
Ezra Cohen, MD
Chief Medical Officer of Oncology, Tempus
External
Frank Weinberg, MD
Assistant Professor, University of Illinois College of Medicine Lead, Thoracic Oncology Program UI Health
-
04/11/2025One Blood Sample, Many Options: The Benefits of Tumor + Normal Match
Part 1 of "Are you getting the full picture? A series on the power of comprehensive intelligent diagnostics."Speakers: Internal
Watch replay
Ezra Cohen, MD
Chief Medical Officer of Oncology, Tempus
External
Rena Callahan, MD
Associate Clinical Professor of Medicine, University of California, Los Angeles
-
03/25/2025
AI & ML in action: Unlocking RWD with GenAI through Tempus Lens
Discover how Tempus is equipping researchers with innovative AI solutions to fully leverage the potential of multimodal data. Gain insights from a panel of leaders across healthcare and life sciences as they discuss the impact of these advanced tools on delivering insights with speed.Speakers: Internal:
Watch replay
Maria Berezina, PhD
VP, Real World Data, Tempus
Jessica Huang, VP
GM of Lens, Tempus
Kathleen Burke, PhD
Senior Director of Computational Biology, Pharma R&D, Tempus
External:
Edwin Posadas, MD
Director, Cancer Therapeutics Program; Medical Director, Center for Uro-Oncology Research Excellence, Cedars-Sinai Cancer
Joshua Watson, PhD
Postdoctoral Scientist, Cedars-Sinai Cancer
-
02/13/2025
AI & ML in action: Real-time advances in precision medicine
Explore the capabilities of the Tempus platform, where cutting-edge diagnostics meet actionable data insights to enhance precision medicine.Speakers: Jonathan Ozeran
Watch replay
SVP, Generative AI and Head of Tempus One, Tempus
Chris Scotto DiVetta
SVP, AI Products, Tempus -
12/05/2024
Advancing IO therapeutics: The convergence of novel biomarkers and combination strategies
Explore the latest in immuno-oncology (IO), where emerging therapies are reshaping the landscape of cancer treatment. This webinar will focus on the role of novel biomarkers and combination treatment strategies in understanding and enhancing the immune system's response to cancer.Speakers: Natalie Vokes, MD
Watch replay
Assistant Professor, MD Anderson Cancer Center
Douglas Palmer, PhD
Executive Director Head IO Translational Medicine, AstraZeneca
Timothy Taxter, MD
Executive Medical Director, Tempus
Calvin Chao, MD
Sr. Vice President of Medical Affairs, Tempus